Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPuma Vct 13 Plc Regulatory News (PU13)

Share Price Information for Puma Vct 13 Plc (PU13)

Share Price is delayed by 15 minutes
Get Live Data
117.50    0.00 (0.00%)
Bid:
110.00
Ask:
125.00
Spread: 15.00 (13.636%)
Market Cap: £243.73m
PU13 Live PriceLast checked at - London Stock Exchange

Intraday Puma Vct 13 Plc Share Chart

Offer Update

27 Jul 2018 12:58

RNS Number : 0397W
Puma VCT 13 PLC
27 July 2018
 

Puma VCT 13 PLC (the "Company")

 

Offer for Subscription

 

A prospectus relating to an offer for subscription of up to £5,000,000 of Ordinary Shares of £0.0005 each, payable in full in cash on application at a price of £1 per Ordinary Share, was issued on 27 July 2018 ("Offer"). The Offer will provide shareholders and new investors with a further opportunity to invest in the Company and benefit from the VCT tax reliefs available to qualifying investors.

 

A copy of the prospectus has been approved by the Financial Conduct Authority and will shortly be available for inspection at the National Storage Mechanism, which is located at: www.morningstar.co.uk/uk/NSM.

Copies of the prospectus are available free of charge from the office of the Company's investment manager, Puma Investment Management Limited, at Bond Street House, 14 Clifford Street, London, W1S 4JU, and also from the Company's website:

http://www.pumainvestments.co.uk/pages/view/investors-information-vcts.

Pursuant to an agreement between the Company and others, and Puma Investment Management Limited, the Companies' investment manager (the "Investment Manager "), which constitutes a smaller related party transactions within Listing Rule 11.1.10 R, the Investment Manager will receive a fee of three (3.0) per cent. of the gross funds raised under the Offer for acting as promoter of the Offer. Out of the fee, the Investment Adviser will pay all costs of the Offer.

 

The Offer is now open and has an initial closing date of no later than 5 April 2019, to be determined at the Directors' absolute discretion.

 

For further information please contact Eliot Kaye on 0207 408 4050.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OUPKMGZNMNNGRZM
Date   Source Headline
30th Jun 20264:15 pmRNSTotal Voting Rights
26th Jun 202611:26 amRNSIssue of Supplementary Prospectus
18th Jun 202611:02 amRNSAdmission of Further Securities to Trading
16th Jun 20262:40 pmRNSIssue of Equity
12th Jun 20262:56 pmRNSAnnual Financial Report for Year Ended 28 Feb 2026
29th May 20264:09 pmRNSTotal Voting Rights
8th May 202610:34 amRNSAdmission of Further Securities to Trading
6th May 202610:21 amRNSIssue of Equity
30th Apr 20264:05 pmRNSTotal Voting Rights
8th Apr 20262:10 pmRNSAdmission of Further Securities to Trading
1st Apr 202610:40 amRNSIssue of Equity
31st Mar 20264:35 pmRNSTotal Voting Rights
31st Mar 202610:24 amRNSAdmission of Further Securities to Trading
27th Mar 202612:30 pmRNSIssue of Equity
25th Mar 20265:01 pmRNSOffer for Subscription – Over-Allotment Facility
25th Mar 20264:39 pmRNSNet Asset Value
19th Mar 202611:49 amRNSAdmission of Further Securities to Trading
13th Mar 202612:46 pmRNSIssue of Equity
27th Feb 20264:00 pmRNSTotal Voting Rights
19th Feb 202611:43 amRNSAdmission of Further Securities to Trading
17th Feb 202612:12 pmRNSIssue of Equity
10th Feb 20263:36 pmRNSAdmission of Further Securities to Trading
5th Feb 20261:05 pmRNSIssue of Equity
30th Jan 20264:03 pmRNSTotal Voting Rights
28th Jan 20265:12 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 202611:05 amRNSIssue of Equity
9th Jan 202611:36 amRNSNet Asset Value
7th Jan 20267:00 amRNSDividend Declaration
31st Dec 202510:17 amRNSTotal Voting Rights
31st Dec 202510:17 amRNSTotal Voting Rights
17th Dec 20253:20 pmRNSIssue of Equity
17th Dec 20253:20 pmRNSIssue of Equity
2nd Dec 20255:09 pmRNSTotal Voting Rights
25th Nov 20259:13 amRNSPortfolio Update
19th Nov 20254:05 pmRNSIssue of Equity
14th Nov 20251:21 pmRNSHalf-year Report
24th Sep 202511:25 amRNSPublication of a Prospectus
22nd Sep 20257:00 amRNSPortfolio Update
21st Aug 20259:37 amRNSNet Asset Value(s)
18th Aug 202512:55 pmRNSResult of AGM
4th Aug 20251:19 pmRNSIntention to Fundraise
10th Jul 20255:20 pmRNSTransaction in Own Shares and Total Voting Rights
24th Jun 202511:20 amRNSPortfolio Update
17th Jun 20255:54 pmRNSAnnual Financial Report for Year Ended 28 Feb 2025
30th May 20254:07 pmRNSTotal Voting Rights
15th May 20253:39 pmRNSIssue of Equity
30th Apr 20254:59 pmRNSTotal Voting Rights
23rd Apr 20255:03 pmRNSIssue of Equity
9th Apr 202511:33 amRNSOffer for Subscription - Update
4th Apr 20256:08 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.